Wendy Stock to Antimitotic Agents
This is a "connection" page, showing publications Wendy Stock has written about Antimitotic Agents.
Connection Strength
0.097
-
Phase I/II multicenter study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD4877 in patients with refractory acute myeloid leukemia. Invest New Drugs. 2012 Jun; 30(3):1107-15.
Score: 0.097